General MedicationsORALGeneric
ZERIT
STAVUDINE
Standard Dose
5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview ZERIT is listed in Drugs@FDA under application 020412 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient STAVUDINE Form and strength CAPSULE;ORAL - 5MG Sponsor BRISTOL Submission history Latest submission status date: 2018-12-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview ZERIT is listed in Drugs@FDA under application 020412 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient STAVUDINE Form and strength CAPSULE;ORAL - 5MG Sponsor BRISTOL Submission history Latest submission status date: 2018-12-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.